SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -5.96%  to  Rs. 5430.90 million from Rs. 5775.40 millions.The Company's Net profit for the September 2024 quarter have declined marginally to Rs. 303.90  millions as against Rs. 345.80 millions reported during the corresponding quarter ended.A decline of 599.20 millions was observed in the OP in the quarter ended September 2024 from 661.60 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5430.90 5775.40 -5.96 10360.50 11691.70 -11.39 22669.10 24979.70 -9.25
Other Income 3.80 7.40 -48.65 4.90 13.90 -64.75 41.80 22.30 87.44
PBIDT 599.20 661.60 -9.43 1142.50 1387.20 -17.64 2703.10 2846.30 -5.03
Interest 71.70 75.50 -5.03 146.30 153.20 -4.50 301.60 325.30 -7.29
PBDT 527.50 586.10 -10.00 996.20 1234.00 -19.27 2401.50 2521.00 -4.74
Depreciation 118.60 117.80 0.68 235.70 235.30 0.17 476.70 472.90 0.80
PBT 408.90 468.30 -12.68 760.50 998.70 -23.85 1924.80 2048.10 -6.02
TAX 105.00 122.50 -14.29 187.50 257.50 -27.18 506.00 520.00 -2.69
Deferred Tax 20.00 12.50 60.00 25.00 20.00 25.00 10.00 -12.50 -180.00
PAT 303.90 345.80 -12.12 573.00 741.20 -22.69 1418.80 1528.10 -7.15
Equity 912.70 919.40 -0.73 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 11.03 11.46 -3.69 11.03 11.86 -7.06 11.92 11.39 4.65

Aarti Drugs Share Price

370.75 0.50 (0.14%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: